Monograph Details
|
|
Gastrointestinal Tract
> Colorectal disorders
|
|
ROWASA |
| Manufacturer |
|
Alaven Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Salicylate. |
| Generic Name |
|
Mesalamine 4g/60mL; enema; contains sulfites. |
| Indications |
|
Mild-to-moderate distal ulcerative colitis, proctosigmoiditis, proctitis. |
| Children |
|
Not recommended. |
| Adults |
|
4g (60mL) daily at bedtime for 3–6 weeks. Retain enema for 8 hours. |
| Precautions |
|
Sulfasalazine allergy. Renal dysfunction; monitor urinalysis, BUN, creatinine. Asthma. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
Acute intolerance syndrome (discontinue if occurs), abdominal cramps, headache, flatulence, GI upset, flu, malaise, fever, sore throat, dizziness, bloating, joint or rectal pain, hemorrhoids, itching, hair loss, pancolitis, pericarditis, rash. |
| How Supplied |
|
Enema—7, 28 |
|
|
|
|
